iSpecimen ( (ISPC) ) has issued an announcement.
iSpecimen Inc. has announced a public offering of approximately $5 million in common stock and pre-funded warrants, with plans to use the proceeds for debt repayment, potential acquisitions, and marketing efforts. WestPark Capital is acting as the exclusive placement agent for this offering, which is expected to close by October 31, 2024. This move aims to bolster iSpecimen’s financial position and support its growth strategy in the biospecimen marketplace.
For a thorough assessment of ISPC stock, go to TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
